These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10569326)

  • 1. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants.
    Michaels AD; Maynard C; Every NR; Barron HV
    Am J Cardiol; 1999 Nov; 84(10):1176-81. PubMed ID: 10569326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
    Voors AA; de Kam PJ; van den Berg MP; Borghi C; Hochman JS; van Veldhuisen DJ; van Gilst WH
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):119-24. PubMed ID: 16025230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
    Wu AH; Parsons L; Every NR; Bates ER;
    J Am Coll Cardiol; 2002 Oct; 40(8):1389-94. PubMed ID: 12392826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).
    Schuler J; Maier B; Behrens S; Thimme W
    Clin Res Cardiol; 2006 Jul; 95(7):360-7. PubMed ID: 16741630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effectiveness of angiotensin-converting enzyme inhibitors after acute myocardial infarction in diabetic versus nondiabetic patients.
    Gottlieb S; Leor J; Shotan A; Harpaz D; Boyko V; Rott D; Mandelzweig L; Behar S;
    Am J Cardiol; 2003 Nov; 92(9):1020-5. PubMed ID: 14583350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
    Berger AK; Duval S; Krumholz HM
    J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.
    Krumholz HM; Vaccarino V; Ellerbeck EF; Kiefe C; Hennen J; Kresowik TF; Gold JA; Jencks SF; Radford MJ
    Am J Cardiol; 1997 Mar; 79(5):581-6. PubMed ID: 9068512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction.
    Krumholz HM; Chen YT; Wang Y; Radford MJ
    Arch Intern Med; 2001 Feb; 161(4):538-44. PubMed ID: 11252112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.
    Fonarow GC; French WJ; Parsons LS; Sun H; Malmgren JA
    Circulation; 2001 Jan; 103(1):38-44. PubMed ID: 11136683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany].
    Wagner S; Schneider S; Schiele R; Fischer F; Dehn H; Grube R; Becker G; Baumgärtel B; Altmann E; Senges J
    Z Kardiol; 1999 Oct; 88(10):857-67. PubMed ID: 10552190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium use in the treatment of acute myocardial infarction in the United States (observations from the Second National Registry of Myocardial Infarction).
    Ziegelstein RC; Hilbe JM; French WJ; Antman EM; Chandra-Strobos N
    Am J Cardiol; 2001 Jan; 87(1):7-10. PubMed ID: 11137825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Schiele R; Gitt AK; Juenger C; Heer T; Meisenzahl C; Landgraf H; Bossaller C; Senges J;
    Am J Cardiol; 2002 Nov; 90(10):1045-9. PubMed ID: 12423701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.
    Gislason GH; Abildstrom SZ; Rasmussen JN; Rasmussen S; Buch P; Gustafsson I; Friberg J; Gadsbøll N; Køber L; Stender S; Madsen M; Torp-Pedersen C
    Scand Cardiovasc J; 2005 Apr; 39(1-2):42-9. PubMed ID: 16097413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.
    Frances CD; Noguchi H; Massie BM; Browner WS; McClellan M
    Arch Intern Med; 2000 Sep; 160(17):2645-50. PubMed ID: 10999979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.
    Shlipak MG; Browner WS; Noguchi H; Massie B; Frances CD; McClellan M
    Am J Med; 2001 Apr; 110(6):425-33. PubMed ID: 11331052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
    Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction.
    Gurwitz JH; Gore JM; Goldberg RJ; Rubison M; Chandra N; Rogers WJ
    Ann Intern Med; 1996 Feb; 124(3):283-91. PubMed ID: 8554222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.